xtandi
astellas pharma europe b.v. - enzalutamide - prostatas audzēji - endokrīnā terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
nebilet 5 mg tabletes
menarini international operations luxembourg s.a., luxembourg - nebivolols - tablete - 5 mg
nebiphar 5 mg tabletes
teva pharma b.v., netherlands - nebivolols - tablete - 5 mg
corbis 10 mg tabletes
unifarma, sia, latvia - bisoprolola fumarāts - tablete - 10 mg
corbis 5 mg tabletes
unifarma, sia, latvia - bisoprolola fumarāts - tablete - 5 mg
bisogamma 5 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - bisoprolola fumarāts - apvalkotā tablete - 5 mg
bisogamma 10 mg apvalkotās tabletes
wörwag pharma gmbh & co.kg, germany - bisoprolola fumarāts - apvalkotā tablete - 10 mg
lodoz 2,5 mg/6,25 mg apvalkotās tabletes
merck serono, sia, latvia - bisoprololi fumaras, hydrochlorothiazidum - apvalkotā tablete - 2,5 mg/6,25 mg
lodoz 10 mg/6,25 mg apvalkotās tabletes
merck serono, sia, latvia - bisoprololi fumaras, hydrochlorothiazidum - apvalkotā tablete - 10 mg/6,25 mg
corvalolum šķidrums iekšķīgai lietošanai
rīgas farmaceitiskā fabrika, a/s, latvia - aethylii bromisovaleras, phenobarbitalum, menthae piperitae aetheroleum - Šķidrums iekšķīgai lietošanai